ARCHIVES

NIDA Supports Phase III Trial of Anti-Tobacco Vaccine

This article is from The Cancer Letter archive.

Vol. 35 No. 41 | November 6, 2009

Download PDF Visit The Full Archive

Related Articles

DRCCA Board, ACCI Agree On New Core Grant Guidelines

February 6, 1981

Conversation with The Cancer Letter: Kazerooni: The Case for Broad Coverage

March 21, 2014

Simone Retires From Academic Medicine, But Plans To Remain Active In Advisory Roles.

September 7, 2001

Group Opposes Bill To Allow Drug Sales After Phase I.

May 26, 2006

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

April 27, 2007

NCI Offers Bibliography On Risk Communication.

March 23, 2001